MAMMOTION's LUBA 3 AWD Robotic Lawn Mower Wins 2026 SEAL Sustainable Product Award
MAMMOTION flagship robotic innovation recognized for leading the shift to sustainable outdoor living LOS ANGELES, Feb. 9, 2026 /PRNewswire/ -- MAMMOTION, the world's No.1 wire-free robotic lawn mower brand[i], today announced that its flagship...
Moomoo Named TradingView's Best Broker for Stocks in North America, Earns Top ETF Honors from BrokerChooser
Global investment platform recognized by TradingView and BrokerChooser for stock breadth, ETF access, and investor experience JERSEY CITY, N.J., Feb. 9, 2026 /PRNewswire/ -- Moomoo, a leading investment and trading platform, today announced it has...
YY Group Holding Announces Total Assets and Net Assets per Share of $1.11 and $0.63, Respectively, as of June 30, 2025
Unaudited Financials Reflect $44.0M in Total Assets and $24.9M in Net Assets SINGAPORE, Feb. 9, 2026 /PRNewswire/ -- YY Group Holding Limited (NASDAQ: YYGH) ("YY Group" or the "Company"), a global leader in on-demand workforce solutions and...
Blue Ocean Technologies Announces Executive Changes
Appoints Robert Virgilio as Chief Compliance Officer of Blue Ocean ATS & Expands South Korean Team with Addition of Daehyun Kim in new Trade Support Role NEW YORK, Feb. 9, 2026 /PRNewswire/ -- Blue Ocean Technologies, LLC, a capital markets...
Global e∙dentity™ Announces End of Conditional Licensing Agreement with FDI Advisory Group
CUPERTINO, Calif., Feb. 9, 2026 /PRNewswire/ -- Global e∙dentity™, a Delaware corporation and leading innovator in multi-factor biometric identity IP-based solutions, today announced that it has ended its November 2025 conditional exclusive global...
DIFF Biotech's Innovative Nasal Spray Influenza Vaccine Receives Clinical Trial Approval, Introducing a New Attenuation Pathway
HANGZHOU, China, Feb. 9, 2026 /PRNewswire/ -- Zhejiang Difference Biological Technology Co., Ltd. (DIFF Biotech) announced that its proprietary nasal spray influenza attenuated live vaccine, DIFF-flu, has recently received clinical trial approval as...
BioDlink Recognized by Client for Enabling the World's First Dual-Payload ADC to Enter Clinical Trials
BioDlink received a formal letter of appreciation from Chengdu Kanghong Pharmaceutical Group for its contribution to advancing KH815, the world's first dual-payload antibody –drug conjugate (ADC) to enter clinical development. BioDlink enabled IND...
Acer Announces January 2026 Revenues at NT$21.08 Billion, Up 39.8% Year-on-year, Highest January Revenue Post Pandemic
TAIPEI, Feb. 9, 2026 /PRNewswire/ -- Acer Inc. (TWSE: 2353) announced its consolidated revenues for January 2026 at NT$21.08 billion, up 39.8% year-on-year (YoY), the highest January revenue post pandemic. Highlights in January include: Revenues...